岸迈生物冲刺港股IPO 公司与三生制药存在渊源

每日经济新闻
Jul 03, 2025

2025年以来,国内创新药颇有久旱逢甘霖之势,而撬动这一局面的关键杠杆是频繁刷屏的“BD”。  BD,即商务拓展(Business Development),是一种通过对外授权实现研发变现的合作模式。简单来说,BD是药企将自主研发的创新药权益授权给跨国药企,以换取首付款、里程碑付款及销售分成,这一模式既能缓解资金压力,又能借助国际巨头的渠道加速产品全球化进程。  《每日经济新闻》记者注意到,近期,...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10